and Host Determinants of Susceptibility to Invasive Candidiasis

1. HornDL, NeofytosD, AnaissieEJ, FishmanJA, SteinbachWJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48: 1695–1703.

2. LionakisMS, LimJK, LeeCC, MurphyPM (2011) Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun 3: 180–199.

3. FelkA, KretschmarM, AlbrechtA, SchallerM, BeinhauerS, et al. (2002) Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun 70: 3689–3700.

4. FillerSG, SheppardDC (2006) Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2: e129 doi:10.1371/journal.ppat.0020129.

5. FinkelJS, MitchellAP (2011) Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 9: 109–118.

6. LiuY, MittalR, SolisNV, PrasadaraoNV, FillerSG (2011) Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog 7: e1002305 doi:10.1371/journal.ppat.1002305.

7. Hennessey JP Jr, Schmidt CS, Ibrahim A, Filler S, White CJ, et al.. (2011). A Phase 1 clinical evaluation of NDV3, a vaccine to prevent disease caused by Candida spp. and Staphylococcus aureus. In 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. Washington, DC: American Society for Microbiology.

8. LinL, IbrahimAS, XuX, FarberJM, AvanesianV, et al. (2009) Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5: e1000703 doi:10.1371/journal.ppat.1000703.

9. LoHJ, KöhlerJR, DiDomenicoB, LoebenbergD, CacciapuotiA, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939–949.

10. MuradAM, LengP, StraffonM, WishartJ, MacaskillS, et al. (2001) NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20: 4742–4752.

11. NeteaMG, BrownGD, KullbergBJ, GowNA (2008) An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67–78.

12. BrownGD (2011) Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 29: 1–21.

13. GringhuisSI, KapteinTM, WeversBA, TheelenB, van der VlistM, et al. (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat Immunol 13: 246–254.

14. WheelerRT, KombeD, AgarwalaSD, FinkGR (2008) Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog 4: e1000227 doi:10.1371/journal.ppat.1000227.

15. RomaniL, MencacciA, CenciE, Del SeroG, BistoniF, et al. (1997) An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J Immunol 158: 2356–2362.

16. NeteaMG, GowNA, JoostenLA, VerschuerenI, van der MeerJW, et al. (2010) Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors. Med Mycol 48: 897–903.

17. ChamilosG, LionakisMS, LewisRE, KontoyiannisDP (2007) Role of mini-host models in the study of medically important fungi. Lancet Infect Dis 7: 42–55.

18. UrbanCF, ErmertD, SchmidM, Abu-AbedU, GoosmannC, et al. (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5: e1000639 doi:10.1371/journal.ppat.1000639.

19. LionakisMS, FischerBS, LimJK, SwamydasM, WanW, et al. (2012) Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathog 8: e1002865 doi:10.1371/journal.ppat.1002865.

20. MajerO, BourgeoisC, ZwolanekF, LassnigC, KerjaschkiD, et al. (2012) Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog 8: e1002811 doi:10.1371/journal.ppat.1002811.

21. LegrandF, LecuitM, DupontB, BellatonE, HuerreM, et al. (2008) Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 46: 696–702.

22. QianQ, JutilaMA, Van RooijenN, CutlerJE (1994) Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 152: 5000–5008.

23. QuintinJ, SaeedS, MartensJH, Giamarellos-BourboulisEJ, IfrimDC, et al. (2012) Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12: 223–232.

24. d'OstianiCF, Del SeroG, BacciA, MontagnoliC, SprecaA, et al. (2000) Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191: 1661–1674.

25. CohenNR, TatituriRV, RiveraA, WattsGF, KimEY, et al. (2011) Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 10: 437–450.

26. LionakisMS (2012) Genetic susceptibility to fungal infections in humans. Curr Fungal Infect Rep 6: 11–22.

27. van SprielAB, SofiM, GartlanKH, van der SchaafA, VerschuerenI, et al. (2009) The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity. PLoS Pathog 5: e1000338 doi:10.1371/journal.ppat.1000338.

28. BärE, GladiatorA, BastidasS, RoschitzkiB, Acha-OrbeaH, et al. (2012) A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J Immunol 188: 5636–5643.

29. PlantingaTS, JohnsonMD, ScottWK, van de VosseE, Velez EdwardsDR, et al. (2012) Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 205: 934–943.

30. JohnsonMD, PlantingaTS, van de VosseE, Velez EdwardsDR, SmithPB, et al. (2012) Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis 54: 502–510.